TP53 and head and neck squamous cell carcinoma: Altogether, these results demonstrate the tumorigenic role of Fra-2 in HNSCC of the tongue and support the possibility that upregulation of p53 via Fra-2 inhibition could sensitize tumors to the treatments [86].